Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.56 |
| ▸ | MEN1 | O00255 | 5/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.56 |
| ▸ | RORC | P51449 | 1/20 | 0.43 |
| ▸ | NLRP3 | Q96P20 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metalaxyl SCHEMBL245477 | 0.99 | KMT2A (0.55) | KMT2AMEN1NPSR1PLA2G1BHTT | |
| Metalaxyl SCHEMBL8852635 | 0.99 | KMT2A (0.55) | KMT2AMEN1NPSR1PLA2G1BHTT | |
| Metalaxyl SCHEMBL20990 | 0.99 | KMT2A (0.58) | KMT2AMEN1NPSR1PLA2G1BHTT | |
| Metalaxyl SCHEMBL55820 | 0.99 | KMT2A (0.58) | KMT2AMEN1NPSR1PLA2G1BHTT | |
| Metalaxyl SCHEMBL8376541 | 0.99 | KMT2A (0.58) | KMT2AMEN1NPSR1PLA2G1BHTT | |
| Metalaxyl SCHEMBL8817105 | 0.99 | KMT2A (0.58) | KMT2AMEN1NPSR1PLA2G1BHTT | |
| Metalaxyl SCHEMBL30058456 | 0.99 | KMT2A (0.58) | KMT2AMEN1NPSR1PLA2G1BHTT | |
| Mefenoxam SCHEMBL22529 | 0.99 | KMT2A (0.58) | KMT2AMEN1NPSR1PLA2G1BHTT | |
| Metalaxyl SCHEMBL5070290 | 0.99 | KMT2A (0.58) | KMT2AMEN1NPSR1PLA2G1BHTT | |
| Metalaxyl SCHEMBL156622 | 0.97 | KMT2A (0.56) | KMT2AMEN1NPSR1PLA2G1BHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7323188-B2 | Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2008-01-29 | — | — | US | disclosed |
| US-7001605-B2 | Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2006-02-21 | — | — | US | disclosed |
| US-20050255171-A1 | Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same | ISHIHARA SANGYO KAISHA, LTD. | 2005-11-17 | — | — | US | disclosed |
| EP-0979034-B1 | COMPOSITION FOR CONTROLLING HARMFUL BIO-ORGANISMS AND METHOD FOR CONTROLLING HARMFUL BIO-ORGANISMS USING THE SAME | ISHIHARA SANGYO KAISHA (JP) | 2003-02-26 | — | — | EP | disclosed |
| US-20020142021-A1 | Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same | ISHIHARA SANGYO KAISHA, LTD. | 2002-10-03 | — | — | US | disclosed |
| US-6375965-B1 | Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2002-04-23 | — | — | US | disclosed |
| EP-0979034-A1 | COMPOSITION FOR CONTROLLING HARMFUL BIO-ORGANISMS AND METHOD FOR CONTROLLING HARMFUL BIO-ORGANISMS USING THE SAME | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2000-02-16 | — | — | EP | disclosed |
| WO-1998048628-A1 | COMPOSITION FOR CONTROLLING HARMFUL BIO-ORGANISMS AND METHOD FOR CONTROLLING HARMFUL BIO-ORGANISMS USING THE SAME | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1998-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050255171-A1 | Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same | IPMK, PPA1, ERG28 | KMT2A 4046/4885MEN1 302/4885NPSR1 3238/4885 |
| US-20020142021-A1 | Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same | PPA1, IPMK, ERG28 | KMT2A 4153/4885MEN1 261/4885NPSR1 3378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.